Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,9 USD | -4,52% | -2,56% | -36,45% |
25/03 | Sectorupdate: Gezondheidszorgaandelen maandag stabiel premarket | MT |
25/03 | Transcript : Esperion Therapeutics, Inc. - Special Call |
Omzet 2024 * | 265 mln. 248 mln. | Omzet 2025 * | 406 mln. 379 mln. | Marktkapitalisatie | 360 mln. 337 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -69 mln. -64,53 mln. | Nettowinst (verlies) 2025 * | 60 mln. 56,12 mln. | EV/omzet 2024 * | 1,36 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,89 x |
K/w-verhouding 2024 * |
-4,71
x | K/w-verhouding 2025 * |
10,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,51% |
Recentste transcriptie over Esperion Therapeutics, Inc.
1 dag | -4,52% | ||
1 week | -2,56% | ||
Lopende maand | -29,10% | ||
1 maand | -29,63% | ||
3 maanden | -10,80% | ||
6 maanden | +160,13% | ||
Lopend jaar | -36,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sheldon Koenig
CEO | Chief Executive Officer | 58 | 15-12-20 |
Director of Finance/CFO | 38 | 01-01-20 | |
JoAnne Foody
CTO | Chief Tech/Sci/R&D Officer | 59 | 28-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 52 | 28-04-22 | |
J. Carroll
CHM | Chairman | 74 | 01-06-22 |
Alan Fuhrman
BRD | Director/Board Member | 67 | 16-03-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 237 M€ | +2,89% | - | |
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,9 | -4,52% | 4 198 930 |
25-04-24 | 1,99 | -6,57% | 5 147 052 |
24-04-24 | 2,13 | +1,91% | 5 684 029 |
23-04-24 | 2,09 | +9,42% | 4 946 560 |
22-04-24 | 1,91 | -2,05% | 4 791 912 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-36,45% | 360 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |